Secondary metabolites (SM) from organisms have served medicinal chemists over the past
two centuries as an almost inexhaustible pool of new drugs, drug-like skeletons, and …

Leishmaniasis is among the neglected diseases that represent 90% of the world burden of
morbidity. According to the WHO, there are 12 million people, mostly deeply impoverished …

Leishmaniasis is among the neglected diseases that represent 90% of the world burden of
morbidity. According to the WHO, there are 12 million people, mostly deeply impoverished …

Leishmaniasis is one of the major parasitic diseases, caused by obligate intracellular
protozoa Leishmania, having high mortality as well as morbidity rate. As there is no human …

Many lignans and neolignans have served as lead compounds for the development of new
drugs. Perhaps the best known example is podophyllotoxin, an antimitotic compound that …

Infections that occur by protozoa are a chief universal issue for health, with wide endemicity
in the involved areas. In the absence of a vaccine, there is an immediate requirement for …

Protozoan parasites are among the most common causative agents of some of the major
tropical diseases occurring in both humans and domestic animals, leading to enormous loss …

Leishmaniasis is a vector-borne parasitic disease caused by protozoan parasites belonging
to the family Trypanosomatidae and genus Leishmania. The disease prevails in 88 …

Leishmaniasis is an infectious disease caused by parasites belonging to the Leishmania
genus. This disease has a prevalence that exceeds 12 million, and approximately 350 …

Leishmaniasis is regarded as a major public health problem, causing significant morbidity
and mortality rates in Africa, Asia and Latin America. The disease currently threatens about …